Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts CPIX Hot Sheet
Join SI Premium – FREE
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.20). Revenue for the quarter came in at $166.45 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herc Holdings (HRI) Tops Q3 EPS by 95c ; Offers Guidance
- Polaris Industries (PII) Tops Q3 EPS by 49c, Beats on Revenue; Offers Strong FY26 EPS Guidance
- CenterPoint Energy (CNP) Tops Q3 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
